SOX2 and neoplasm: In head and neck squamous cell carcinoma [28], PSMD14 can influence tumor cell proliferation, drug resistance, and cell stemness by blocking E2F1 ubiquitination and degradation, boosting Akt pathway activation, and promoting SOX2 transcription.